electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025
electroCore (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has scheduled its fourth quarter and full year 2024 financial results announcement for Wednesday, March 12, 2025, after market close. The company will host a webcast and conference call at 5:30 PM EDT where management will discuss the financial results and conduct a Q&A session.
electroCore (Nasdaq: ECOR), un'azienda di medicina bioelettronica e benessere in fase commerciale, ha programmato l'annuncio dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per mercoledì 12 marzo 2025, dopo la chiusura del mercato. L'azienda ospiterà un webcast e una conferenza telefonica alle 17:30 EDT, durante i quali la direzione discuterà i risultati finanziari e condurrà una sessione di domande e risposte.
electroCore (Nasdaq: ECOR), una empresa de medicina bioelectrónica y bienestar en etapa comercial, ha programado el anuncio de sus resultados financieros del cuarto trimestre y del año completo 2024 para miércoles, 12 de marzo de 2025, después del cierre del mercado. La compañía llevará a cabo un webcast y una conferencia telefónica a las 5:30 PM EDT, donde la dirección discutirá los resultados financieros y realizará una sesión de preguntas y respuestas.
electroCore (Nasdaq: ECOR), 상업 단계의 생체 전자 의학 및 웰니스 회사는 2024년 4분기 및 전체 연도 재무 결과 발표를 2025년 3월 12일 수요일 시장 마감 후에 예정하고 있습니다. 회사는 오후 5시 30분 EDT에 웹캐스트 및 컨퍼런스 콜을 개최하며, 경영진이 재무 결과를 논의하고 Q&A 세션을 진행할 것입니다.
electroCore (Nasdaq: ECOR), une entreprise de médecine bioélectronique et de bien-être en phase commerciale, a programmé l'annonce de ses résultats financiers du quatrième trimestre et de l'année entière 2024 pour mercredi 12 mars 2025, après la fermeture du marché. L'entreprise organisera un webcast et une conférence téléphonique à 17h30 EDT, où la direction discutera des résultats financiers et animera une session de questions-réponses.
electroCore (Nasdaq: ECOR), ein Unternehmen für bioelektronische Medizin und Wellness in der kommerziellen Phase, hat die Bekanntgabe seiner finanziellen Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 für Mittwoch, den 12. März 2025, nach Börsenschluss angesetzt. Das Unternehmen wird um 17:30 Uhr EDT ein Webcast und eine Telefonkonferenz veranstalten, in der das Management die finanziellen Ergebnisse besprechen und eine Q&A-Session durchführen wird.
- None.
- None.
ROCKAWAY, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report its financial results for the fourth quarter and full year ended December 31, 2024, after market close on Wednesday, March 12, 2025.
Management will host a webcast and conference call at 5:30 PM EDT to discuss the financial results and answer questions.
Conference Call & Webcast Details
Date: Wednesday, March 12, 2025
Time: 5:30 PM EDT
Registration: Click here to register to receive login credentials and dial-in details.
About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine and wellness company dedicated to improving health and promoting general wellness through its non-invasive vagus nerve stimulation (nVNS) technology platform. The company focuses on commercializing medical devices for managing and treating specific medical conditions, as well as consumer products utilizing nVNS to enhance general well-being and human performance in the United States and select international markets.
For more information, visit www.electrocore.com.
Contact:
ECOR Investor Relations
(973) 302-9253
Investors@electrocore.com
FAQ
When will electroCore (ECOR) release Q4 and full year 2024 earnings?
What time is electroCore's (ECOR) Q4 2024 earnings call?
How can investors access electroCore's (ECOR) Q4 2024 earnings call?
What period will electroCore's (ECOR) upcoming earnings report cover?
